Biotech IV Monitor

loading…

Which biotechs is the options market bracing for?

A clinical readout is one of the few genuinely binary events in finance — the drug works or it doesn't, and the answer lands on a single day. Implied volatility is what traders are paying to be protected when it does. This tracks it across 107 mid- and large-cap biotechs, next to the trial dates and SEC filings that explain it.

Free, no account needed · upcoming readout calendar · browse all companies

🛡️ Collar guide 📅 Add dates to my calendar

Watchlist

🎯 Buyout pattern screen companies resembling past acquisition targets

Contact — questions, corrections, or a company you want added: dukeupt@gmail.com
IV is ATM ~30-day implied volatility computed from CBOE delayed options data (Barchart fallback); a * marks a carried-forward value whose source was briefly unavailable. 30d implied move = price × IV × √(30/365): the ±1σ range the options market prices for the next month (moves through a catalyst can far exceed it). Targets are third-party Wall Street analyst estimates via stockanalysis.com (S&P Global), refreshed daily (consensus; bull = Street-high, a proxy for trial success; bear = Street-low, a proxy for failure). Upside % is computed against the live price. Frequently wrong around binary readouts — research tooling, not investment advice.